ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S.-based, end-to-end commercial biopharmaceutical company ...

Kashiv BioSciences, LLC ("Kashiv"), a vertically integrated biopharmaceutical company, today announced that Dr. Sandeep ...

J.P. Morgan's top defensive-growth idea, with shares expected to re-rate up "on robust EBITDA accretion from renewable ...

CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026Planned milestones include pivotal dose selection, ...

Agios is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. To learn more, visit and follow us on LinkedIn and X. Contacts: Investor Contact Morgan Sanford, Vice ...

JPMorgan Chase has announced a slew of changes to local leadership over the past few months. Now, it's tapped a new head of ...

Austin, Texas, United States, January 5th, 2026, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...

A live webcast of the presentation will be available in the Investor section of the Company's website at www.syndax.com, where a replay will also be available for a limited time.

According to reports from The New York Times and The Economic Times, Dimon recorded a total economic gain of roughly $770 ...

The transaction, completed on behalf of Galaxy, which also acted as the structurer, marks one of the first debt issuances ever executed on a public blockchain Coinbase was the lead investor, alongside ...

In December 2025, J.P. Morgan upgraded Recursion Pharmaceuticals after REC-4881 showed rapid, durable polyp burden reductions and a favorable safety profile in familial adenomatous polyposis patients, ...

Nxera Pharma Co., Ltd. ('Nxera” or 'the Company”; TSE 4565) announces that Chris Cargill, President and CEO, will present at ...